Peptidesfor liverrepair Peptides are showing significant promise as novel therapeutic agents for fatty liver disease, a condition characterized by the accumulation of excess fat in the liver. Research is actively exploring various peptide compounds that can help reduce liver fat, improve liver function, and even reverse the progression of the disease. From naturally occurring hormones to synthesized molecules, these peptides offer a range of mechanisms to combat fatty liver, including regulating fat metabolism, reducing inflammation, and improving insulin sensitivity.
Several specific peptides have emerged as leading candidates in the research and development of fatty liver treatments. These include:
* Glucagon-Like Peptide-1 (GLP-1) Analogs: GLP-1 is a naturally occurring peptide hormone that plays a crucial role in regulating glucose metabolism and appetite.Vitamins and supplements for fatty liver disease (MASLD) - Mayo Clinic GLP-1 receptor agonists (GLP-1 RAs), such as liraglutide and semaglutide, have demonstrated significant efficacy in improving fatty liver disease. They work by enhancing insulin secretion, reducing glucagon levels, promoting weight loss, and directly impacting hepatic fat accumulation and inflammation. Tirzepatide, a dual GIP and GLP-1 receptor agonist, has also shown promising results in reducing liver fat content in clinical trialsPlant-derived bioactive peptides and protein hydrolysates ....
* Fibroblast Growth Factor 21 (FGF21) Analogs: FGF21 is another hormone involved in metabolic regulation. Analogs of FGF21 are being investigated for their potential to improve insulin sensitivity and lipid metabolism, thereby alleviating fatty liver.
* Metabolitin: This newly identified peptide hormone has shown to inhibit intestinal fat absorption and improve systemic insulin resistance, offering a unique approach to managing fatty liver.
* Kisspeptin: Research suggests that kisspeptin can help reduce fat deposition in the liver and potentially reverse more advanced stages of the disease.作者：G Santos-Sánchez·2025·被引用次数：3—Biopeptides exert beneficial effects on metabolic-associated fatty liver disease. Biopeptides possess effects on fatty acid metabolism, ...
* PGPIPN: This therapeutic hexapeptide, derived from bovine β-casein, has demonstrated a role in preventing and treating alcoholic fatty liver disease by influencing lipid metabolismGlucagon-Like Peptide-1 Receptor Agonists for Non- ....
* Corn Peptides: Peptides derived from corn have shown to improve obesity-induced non-alcoholic fatty liver disease (NAFLD) by relieving lipid metabolism, insulin resistance, and oxidative stress作者：HA Lee·2023·被引用次数：39—GLP-1 is a peptide hormoneproduced by gut enteroendocrine cells that affects the secretion of insulin and glucagon, food intake, and gut .... Some studies also indicate that corn-derived sEH inhibitory peptides possess hepatoprotective activity against nonalcoholic fatty liver fibrosisGlucagon‐like Peptide‐1 Improves Fatty Liver and ....
* Retatrutide: This experimental drug targets multiple metabolic conditions, including obesity and type 2 diabetes, and has shown a significant reduction in liver fat in obese patients with fatty liver diseaseGlucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon ....
The diverse range of peptides being studied employ several key mechanisms to combat fatty liver disease:
* Metabolic Regulation: Many peptides, particularly GLP-1 analogs, directly influence glucose and lipid metabolism. They can enhance insulin sensitivity, reduce the production of glucose by the liver, and promote the uptake and utilization of fatty acids, thereby decreasing fat accumulation.
* Appetite Control and Weight Management: Peptides like GLP-1 and FGF21 can reduce appetite and increase feelings of fullness, leading to weight loss. Since obesity is a major driver of NAFLD, this effect is critical in improving liver health.作者：HA Lee·2023·被引用次数：39—GLP-1 is a peptide hormoneproduced by gut enteroendocrine cells that affects the secretion of insulin and glucagon, food intake, and gut ...
* Anti-inflammatory Effects: Chronic inflammation is a hallmark of progressive fatty liver disease, particularly non-alcoholic steatohepatitis (NASH). Some peptides have been shown to modulate inflammatory pathways, such as inhibiting the NLRP3 inflammasome, thereby reducing liver inflammationPeptide Polyagonists for the Treatment of Nonalcoholic ....
* Lipid Metabolism Modulation: Peptides can directly impact how the body processes fats. For example, some peptides inhibit fatty acid absorption in the intestine, while others influence the pathways involved in fatty acid synthesis and oxidation within the liverNewly identified peptide hormone inhibits intestinal fat ....
* Hepatoprotective Effects: Certain peptides, like those derived from plants or specific protein hydrolysates, have demonstrated direct protective effects on liver cells, mitigating damage caused by fat accumulation and oxidative stress.
While the research into peptide therapies for fatty liver disease is highly encouraging, several factors warrant consideration. Many of these peptides are still in various stages of clinical development, and further large-scale human trials are needed to confirm their long-term efficacy and safety. The precise mechanisms of action for some peptides are still being elucidated, and understanding these pathways could lead to even more targeted and effective treatments.
Furthermore, the identification of specific peptides as risk factors, such as fasting C-peptide in relation to NAFLD, highlights the complex interplay of various biological markers in liver health. As research progresses, peptide-based interventions are poised to become a significant component of comprehensive strategies for managing and treating fatty liver disease, offering hope for improved patient outcomes.
Join the newsletter to receive news, updates, new products and freebies in your inbox.